zara steinmeyer

zara steinmeyer


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MBMorwenn Le Boulc’h
Morwenn Le Boulc’h
JGJulia Gilhodes
Julia Gilhodes
ZSzara steinmeyer
zara steinmeyer
SMSébastien Molière
Sébastien Molière
CMCAROLE MATHELIN
CAROLE MATHELIN
Background: This systematic review aimed at comparing performances of ultrasonography (US), magnetic resonance imaging (MRI), and fluorodeoxyglucose positron emission tomography (PET) for axillary staging, with a focus on micro- or micrometastases. Methods: A search for relevant studies published between January 2002 and March 2018 was conducted in MEDLINE database. Study quality was assessed using the QUality Assessment of Diagnostic Accuracy Studies checklist. Sensitivity and specificity were meta-analyzed using a bivariate random effects approach; Results: Across 62 studies (n = 10,374 patients), sensitivity and specificity to detect metastatic ALN were, respectively, 51% (95% CI: 43–59%) and 100% (95% CI: 99–100%) for US, 83% (95% CI: 72–91%) and 85% (95% CI: 72–92%) for MRI, and 49% (95% CI: 39–59%) and 94% (95% CI: 91–96%) for PET. Interestingly, US detects a significant proportion of macrometastases (false negative rate was 0.28 (0.22, 0.34) for more than 2 metastatic ALN and 0.96 (0.86, 0.99) for micrometastases). In contrast, PET tends to detect a significant proportion of micrometastases (true positive rate = 0.41 (0.29, 0.54)). Data are not available for MRI. Conclusions: In comparison with MRI and PET Fluorodeoxyglucose (FDG), US is an effective technique for axillary triage, especially to detect high metastatic burden without upstaging majority of micrometastases.

27 September 2020 in Geriatrics
Verified
Journal Article
Open access
PDF file
ZSzara steinmeyer
zara steinmeyer
SVSara Vienne-Noyes
Sara Vienne-Noyes
MBMarc Bernard
Marc Bernard
ASArmand Steinmeyer
Armand Steinmeyer
LBLaurent Balardy
Laurent Balardy
SSSandrine Sourdet
Sandrine Sourdet
(1) Background: COVID-19 has become a global pandemic and older patients present higher mortality rates. However, studies on the characteristics of this population set are limited. The objective of this study is to describe clinical characteristics and outcomes of older patients hospitalized with COVID-19. (2) Methods: This retrospective cohort study was conducted from March to May 2020 and took place in three acute geriatric wards in France. Older patients hospitalized for COVID-19 infections were included. We collected clinical, radiological, and laboratory outcomes. (3) Results: Ninety-four patients were hospitalized and included in the final analysis. Mean age was 85.5 years and 55% were female. Sixty-four (68%) patients were confirmed COVID-19 cases and 30 (32%) were probable. A majority of patients were dependent (77%), 45% were malnourished, and the mean number of comorbidities was high in accordance with the CIRS-G score (12.3 ± 25.6). The leading causes of hospitalization were fever (30%), dyspnea (28%), and geriatric syndromes (falls, delirium, malaise) (18%). Upon follow-up, 32% presented acute respiratory failure and 30% a geriatric complication. Frailty and geriatric characteristics were not correlated with mortality. Acute respiratory failure (p = 0.03) and lymphopenia (p = 0.02) were significantly associated with mortality. (4) Conclusions: Among older patients hospitalized with COVID-19, clinical presentations were frequently atypical and complications occurred frequently. Frailty and geriatric characteristics were not correlated with mortality.

23 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAntoine Piau
Antoine Piau
ZSzara steinmeyer
zara steinmeyer
NMNora Mattek
Nora Mattek
ALAllison Lindauer
Allison Lindauer
NSNicole Sharma
Nicole Sharma
JBJoan Benedict
Joan Benedict
(1) Background: The development of assistive technologies has become a key solution to reduce caregiver burden. The objective of this study was to survey caregivers on perceptions and beliefs about the future of modern technology in caregiving. (2) Methods: Demographics and clinical caregiver characteristics were collected via an online survey along with the perceptions and willingness to adopt technologies to support caregiving. Comparisons were made between those who considered themselves caregivers and those who never did. (3) Results: 398 responses (mean age 65) were analyzed. Health and caregiving status of the respondents (e.g., schedule of care) and of the care recipient were described. The perceptions and willingness to use technologies were generally positive without significant differences between those who ever considered themselves as caregivers and those who never did. The most valued features were the monitoring of falls (81%), medication use (78%), and changes in physical functioning (73%). For caregiving support, the greatest endorsements were reported for one-on-one options with similar scores for both online and in-person alternatives. Important concerns were expressed about privacy, obtrusiveness, and technological maturity. (4) Conclusions: Online surveys as a source of health information on caregiving may be an effective guide in developing care-assisting technologies receiving end users’ feedback. Caregiver experience, whether positive or negative, was correlated to health habits such as alcohol use or sleep. This study provides insight on caregivers’ needs and perceptions regarding caregiving according to their socio-demographic and health status.

5 December 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SCStéphanie Cazalbou
Stéphanie Cazalbou
LNLouise Naccache
Louise Naccache
SSSandrine Sourdet
Sandrine Sourdet
ECEve Cariou
Eve Cariou
PFPauline Fournier
Pauline Fournier
ONon behalf of the Toulouse Amyloidosis Research Network
on behalf of the Toulouse Amyloidosis Research Network
Background—Transthyretin cardiac amyloidosis (ATTR-CA) prevalence increases with age. The interplay between frailty and heart failure has been increasingly recognized. The objective of this study is to compare clinical, biological, and transthoracic echocardiography (TTE) characteristics of older ATTR-CA patients according to the G8 frailty screening tool. Methods—Patients over 75 years old with a confirmed diagnosis of ATTR-CA were included between January 2020 and April 2021. All patients underwent a routine blood test, TTE, and a functional assessment with a six-minute walking distance test (6MWD) or cardiopulmonary exercise testing (CPET), and the G8 score was calculated. Results—Fifty-two patients were included. Thirty-nine (75%) patients were frail and their mean NYHA stage was more severe (2.2 vs. 1.7; p = 0.004); 62% of them had a Gilmore stage of 2 or 3 (p = 0.05). Global left ventricular strain (GLS) was lower (−11.7% vs. −14.9%; p = 0.014) and the interventricular septum was thicker (18 ± 2 mm vs. 17 ± 2 mm; p = 0.033) in frail patients. There were no significant differences according to functional tests. Conclusion—The majority of older patients with ATTR-CA are frail according to the G8 score. They are more symptomatic and have an increased cardiac involvement and a poorer prognosis, requiring more personalized cardiac management.

22 January 2024 in The Journal of Frailty & Aging
Verified
Journal Article
Open access
PDF file
ZSzara steinmeyer
zara steinmeyer
CBC. Berbon
C. Berbon
SSS. Sourdet
S. Sourdet
SGS. Gérard
S. Gérard
YRY. Rolland
Y. Rolland
LBL. Balardy
L. Balardy

26 April 2025 in Journal of Geriatric Oncology
Verified
Journal Article
Open access
ZSzara steinmeyer
zara steinmeyer
CBCaroline Berbon
Caroline Berbon
APAstride Piquart
Astride Piquart
SGStéphane GERARD
Stéphane GERARD
RYRolland Yves
Rolland Yves
LBLaurent Balardy
Laurent Balardy
Comprehensive geriatric assessment (CGA) can prevent functional decline in patients with hematological malignancies (HM). The Integrated Care for Older People (ICOPE) program has been developed to monitor intrinsic capacity (IC) and to propose patient-centred interventions to prevent functional decline. ICOPE may also be relevant in older adults with HM. The objective of this study was to describe IC in older patients with HM. Patients aged above 60 years old diagnosed with a HM, with an activities of daily living (ADL) score ≥ 5, were recruited from the Oncological Geriatric department of the Toulouse University Hospital during routine cancer assessment. The ICOPE Step 1 was implemented in all participants using a digital tool. IC was assessed in these domains: cognition, mobility, nutrition, mood, vision, and hearing. A follow-up Step 1 was proposed systematically at six months. A total of 403 patients with HM aged 82 (±6.5) years underwent a Step 1 assessment. Three hundred and seventy-one (92.1 %) patients presented an altered Step 1 assessment with 2.4 ± 1.4 altered IC domains. The most frequent altered domains were cognition in 203 (50.4 %), hearing in 193 (47.9 %), and mobility in 177 (43.9 %). Two hundred twelve (65.8 %) underwent a Step 1 follow-up at six months. ONCO-ICOPE provides an innovative framework to assess and monitor IC in patients with HM at high risk of functional decline. With a digital solution, its objective is to expand IC assessment and bridge the gap between primary care and oncologic care for a more personalized patient care plan.